Jobs / United States / Astrazeneca Pharmaceuticals Lp
US Scientific Communications Senior Director
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Wilmington - DE
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 1 day agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Location: Wilmington, Delaware Hybrid: 3 days a week onsite The Senior Director, US Scientific Communications sets the strategic agenda for the US Scientific Communications function and is accountable for building and evolving a high-performing US Scientific Communications function that defines the overall US medical content development strategy and enhances the quality, reach, and impact of scientific communications deliverables, as well as delivers on license to operate work (Medical Information activities and US Promotional review) The US SciComms Senior Director reports to the Head of US Medical Excellence, and partners closely with the core functions under the US Medical Excellence team, US Medical Affairs and US Commercial Brand and Therapy Areas teams, Global Scientific Communications, Promotional Regulatory Affairs, Legal, Compliance, Global Business Services (GBS), enterprise digital teams, and external agencies or platform partners. Typical Accountabilities: Strategic Leadership and Operating Model • Functional strategy and transformation: Set the long-term vision, priorities, and transformation agenda for US Scientific Communications, ensuring the function drives scientific narrative pull-through, strategic impact, and measurable value across US BBU • US content strategy and global-to-local evolution: Define and lead the US medical content strategy, including reimagining the global-to-local process to improve prioritization, relevance, reuse, governance, and delivery of high-impact scientific content. • Evolve and lead the current operating model supporting Medical Information and promotional review activities, identifying and implementing opportunities to enhance efficiency, quality, and stakeholder experience while maintaining regulatory compliance. • Content excellence and performance: Establish standards, KPIs, and feedback loops that elevate quality, speed, accessibility, discoverability, compliance, and measurable content impact. • Innovation and AI-enabled transformation: Champion future-ready approaches, including agentic AI and automation, to modernize content creation, review, delivery, and workflow design. • Future-ready operating model: Build and evolve a modern SciComms operating model that integrates license-to-operate responsibilities with scalable content strategy, agile ways of working, and continuous improvement. Enterprise Collaboration • US Medical and TA partnership: Partner with US Medical, TA, and Commercial leaders to align SciComms priorities with Medical Plans, brand needs, key milestones, and business objectives. • Global Scientific Communications partnership: Partner with Global SciComms to improve content pull-through while ensuring US insights, market needs, customer trends, and performance metrics shape global planning. • Enterprise thought leadership: Serve as a strategic enterprise partner, bringing SciComms expertise, innovation, and best practices into broader US business priorities. • GBS and internal partner leadership: Coordinate both GBS and in-house delivery collaborations to ensure clear service build, sourcing, demand management, quality oversight, and handling of blocking issues. Team Management and Resources • Resource and milestone readiness: Plan and manage resources to support TA priorities and ensure readiness for launches, data readouts, congresses, and other critical business moments. • Financial and vendor stewardship: Lead budget planning and oversee agency, third-party, and vendor investments to ensure spend is strategically allocated and tied to measurable value. • Talent and capability development: Build, mentor, and develop a high-performing SciComms team, advancing capabilities in content strategy, innovation, operational excellenc